Search clinical trials for: Administration of ceralasertib and olaparib

Total 147999 results

Ottawa Hospital Research Institute

Recruiting

Evaluating an Endocrine Therapy Dose-frequency Escalation Strategy and Its Effects on Tolerability and Compliance (REaCT-TEMPO)

Breast Cancer

Canada
Institut fuer Frauengesundheit
Merck Sharp & Dohme LLC

Active, not recruiting

Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients With Unresectable or Metastatic HER2 Negative Breast Cancer and a Deleterious Germline Mutation or a Homologous Recombination Deficiency (COMPRENDO (COMPRENDO)

Breast Cancer | Malignant Neoplasm of Breast

Germany
IRCCS San Raffaele
GlaxoSmithKline

Not yet recruiting

Antiviral Long Acting Drugs Landing in People Living With HIV (ALADDIN)

HIV | Antiviral Agents

Italy
Seoul National University Hospital

Unknown

Methylene Blue in Severe Sepsis and Septic Shock

Septic Shock | Severe Sepsis

Korea, Republic of
Red Nucleus Enterprise Solutions, LLC

Recruiting

NSAA NON-Interventional Study Protocol

Duchenne Muscular Dystrophy

United States
Fondation Ophtalmologique Adolphe de Rothschild

Recruiting

Efficacy of Pulmozyme® on Arterial Recanalization in Post-thrombectomy Patients Managed for Ischemic Stroke (NETs-target) (NETs-target)

Ischemic Stroke

France
Fresenius Medical Care Deutschland GmbH
acromion GmbH; Vector Psychometric Group, LLC

Completed

Development, Feasibility Testing and Validation of a Survey Set to Measure Patient-Reported Outcomes Among Hemodialysis Patients in Turkey (DOPRO)

Renal Failure | End Stage Renal Disease

Turkey
Guangdong Provincial People's Hospital

Completed

Pathological Tumor and Lymph Node Responses After Neoadjuvant Immunochemotherapy in Initially-unresectable NSCLC

Chemotherapy | Non Small Cell Lung Cancer | Immunotherapy | Tumour, Residual

China
Yonsei University

Completed

A 24 Week, Multicenter, Prospective, Open-labeled, Single-arm, Exploratory Phase 4 Clinical Trial to Evaluate the Safety and Efficacy of Lobeglitazone in Decreasing Intrahepatic Fat Contents in Type 2 Diabetes With NAFLD

Type 2 Diabetes | Non-alcoholic Fatty Liver Disease

Korea, Republic of
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer

Pancreatic Cancer

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Open Labeled Placebo in Reducing Cancer Related Fatigue in Patients With Advanced Cancer

Advanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Geriatric Assessment in Predicting Chemotherapy Toxicity and Vulnerabilities in Older Patients With Cancer

Solid Neoplasm

United States
IFOM ETS - The AIRC Institute of Molecular Oncology
AstraZeneca

Recruiting

Restoring Sensitivity To Immunotherapy In Advanced Triple Negative Breast Cancer Exploiting Ceralasertib Priming Followed By Combined Durvalumab/Nab-Paclitaxel (ATRiBRAVE)

Triple Negative Breast Cancer Metastatic

Italy
Assistance Publique Hopitaux De Marseille

Active, not recruiting

Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance (PIONeeR)

Non-small Cell Lung Cancer

France
Fondazione Poliambulanza Istituto Ospedaliero

Completed

Prevention of Hypoglycaemia by Oral 40% Destrogel

Hypoglycaemia Neonatal

Italy
BioMarin Pharmaceutical

Completed

A Phase 3 Substudy to Evaluate Executive Function in Adults With PKU Who Are Participating in the Phase 3 Study, 165-302 (PRISM303)

Phenylketonuria

United States
Fayoum University

Completed

Administration of Systemic Corticosteroids and the Recovery of Gustatory Functions in Patients With COVID-19

COVID-19 | Olfactory Dysfunction

Egypt
Genesis Center for Fertility & Human Pre-Implantation...

Unknown

A Novel Stimulation Protocol and the Conventional Low Dose Step-up and Step Down Regimens

PCOS

Cyprus
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old

Pertussis | Tetanus | Diphtheria | Poliomyelitis

France, Germany
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Study of Fecal Microbiota Transplantation (FMT) in Severe IBS Patients (ICEBOAT)

Irritable Bowel Syndrome

France
Fertilys
Institut National de la Recherche Scientifique - Centre Armand Frappier Santé...

Completed

Endometrium Immunomodulation by in Utero Administration of Peripheral Blood Mononuclear Cells

Infertility

Canada
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Withdrawn

Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer

Stage II Uterine Corpus Cancer AJCC v7 | Uterine Carcinosarcoma | Endometrial Carcinoma | Stage II Cervical Cancer AJCC v7 | Stage IIA Cervical Cancer AJCC v7 | Stage IIB Cervical Cancer AJCC v6 and v7 | Stage IIIB Cervical Cancer AJCC v6 and v7 | Stage IVA Cervical Cancer AJCC v6 and v7 | Stage 0 Fallopian... and other conditions

United States
Assistance Publique - Hôpitaux de Paris

Recruiting

Lessening Organ Dysfunction With VITamin C in Septic ARDS (LOVIT ARDS)

Acute Respiratory Distress Syndrome | Septic

France
National Cancer Centre, Singapore
Merck Sharp & Dohme LLC; National Medical Research Council (NMRC), Singapore

Not yet recruiting

Pembrolizumab and Olaparib Treatment for Relapsed or Refractory Peripheral T-Cell Lymphoma (POLAR)

Refractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell Lymphoma

Singapore
Fondazione Ricerca Traslazionale

Recruiting

Randomized Trial Comparing Standard of Care Versus Immune- Based Combination in Relapsed Stage III Non-small-cell Lung Cancer (NSCLC) Pretreated With Chemoradiotherapy and Durvalumab

Non-small-cell Lung Cancer Patients

Italy
MedSIR

Terminated

Olaparib+Trastuzumab in HER2[+],Breast Cancer Susceptibility Gene (BRCA) Mutated Advanced Breast Cancer (OPHELIA)

Advanced Breast Cancer

Spain
Shriners Hospitals for Children
University of Kentucky; Kosair Charities, Inc.

Completed

A Randomized Controlled Trial of Three Non-pharmacologic Analgesic Techniques for Casting of Clubfoot Infants

Clubfoot
University of California, San Francisco
Mount Zion Health Fund

Completed

Incorporating ePrognosis for the Encouragement of Smarter Screening for Breast and Colorectal Cancer in Older Adults

Breast Carcinoma | Colorectal Carcinoma

United States
Abramson Cancer Center at Penn Medicine

Recruiting

Second Window Indocyanine Green for All Nervous System Tumors

Nervous System Tumor

United States
Fisher and Paykel Healthcare

Completed

Adherence Risk Indicator Validation Study (ARI)

Obstructive Sleep Apnea

United States
Eurofarma Laboratorios S.A.

Not yet recruiting

Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in Brazil (ALERZIN)

Allergic Rhinitis

Brazil
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France

Completed

Reducing Neonatal Morbidity by Discontinuing Oxytocin During the Active Phase of 1st Stage of Labor (STOPOXY)

Neonatal Morbidity

France
AstraZeneca

Completed

A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer

Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma

Spain, Poland, Hungary, Ukraine, Germany
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Not yet recruiting

First-line Olaparib Combined With Bevacizumab Maintenance Therapy

Ovarian Neoplasms
Leiden University Medical Center
Radboud University Medical Center; AstraZeneca; University Medical Center Groningen and other collaborators

Active, not recruiting

Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer (DOMEC)

Uterine Neoplasms | Endometrial Neoplasms | Endometrium Cancer

Netherlands
Mayo Clinic

Recruiting

Reishi Mushroom Extract for Fatigue and/or Arthralgias/Myalgias in Patients With Breast Cancer on Aromatase Inhibitors

Estrogen Receptor-Positive Breast Carcinoma

United States
Istanbul Aydın University

Completed

SF-QUALIVEEN Turkish Validity and Reliability Study

Multiple Sclerosis

Turkey
Instituto Bernabeu

Completed

Follicular Phase Stimulation vs. Luteal Phase Stimulation in Patients Diagnosed With Suboptimal Response (SUBLUTEAL)

Improving Ovarian Stimulation; Suboptimal Responders

Spain
Hebei Medical University Fourth Hospital

Not yet recruiting

Olaparib in the Treatment of BRCA1/2 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast Cancer

Solid Tumor
National Cancer Institute (NCI)

Recruiting

Olaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma

Pancreatic Acinar Cell Carcinoma

United States
AstraZeneca

Enrolling by invitation

Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib (ROSY-O)

Breast Cancer | Ovarian Cancer

Italy, Spain, United States, Canada, Belgium, Denmark, Korea, Republic of, Czechia, Turkey, China, United Kingdom, Taiwan, Brazil, Israel, France, Hungary, Poland, Portugal, Germany, Russian Federation, Bulgaria, Finland, Slovenia, Sw...
ARCAGY/ GINECO GROUP
AstraZeneca

Completed

Real-life Data of Olaparib in Relapsed Ovarian Cancers Patients (RETROLA)

Relapsed Ovarian Cancers Patients

France
Royal Marsden NHS Foundation Trust
AstraZeneca

Unknown

A Translational Study of Single Agent Olaparib in the Treatment of Advanced Oesophagogastric Cancer (SOLAR)

Gastric Cancer | Oesophageal Cancer | Gastro-Oesophageal Junction Cancer

United Kingdom
Toujinkai Hospital

Completed

Effect of Carnitine on Uremic Cardiomyopathy

Disorder of Fatty Acid Metabolism
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Differences in Timely Cancer Diagnosis in African American and Caucasian Patients With Newly Diagnosed Colorectal Cancer

Colorectal Cancer

United States
Istituti Clinici Scientifici Maugeri SpA

Recruiting

Pain and Autonomic Symptoms in Parkinson's Disease and Atypical Parkinsonisms

Parkinson Disease | Multiple System Atrophy

Italy
Maimónides Biomedical Research Institute of Córdoba

Unknown

Clinical Trial for Valuation of the Effectiveness of Lactoferrine in the Prevention of Sepsis in New Premature Born. Bimonitorization of the Antinflammatory Mechanisms, Antioxidants and the Intestinal Microbiote. (LACTOPREM)

SEPSIS SYNDROME

Spain
German Cancer Research Center

Recruiting

FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer (CoRe_CC-3)

Colorectal Cancer

Germany
Medical University Innsbruck

Completed

Study to Reveal if Fibrinogen Treatment Effects Blood Clotting Better Than a Platelet Transfusion (FiT2012)

Blood Clotting | Blood Platelet Transfusion

Austria, Denmark
City of Hope Medical Center
National Cancer Institute (NCI); Hope Foundation

Completed

Personalized Dietary Intervention in Managing Bowel Dysfunction and Improving Quality of Life in Stage I-III Rectosigmoid Cancer Survivors

Cancer Survivor | Stage I Rectosigmoid Cancer | Stage II Rectosigmoid Cancer | Stage III Rectosigmoid Cancer

United States

Search clinical trials for: Administration of ceralasertib and olaparib

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations